In this current study, we conducted co-immunoprecipitation (Co-IP) and found that KRT19 interacts with β-catenin alone in colon cancer cells and with the β-catenin/RAC1 complex in breast cancer cells (Figure 5c). The gene discussed is RAC1; the disease is breast carcinoma.